About STDCO

Founded in the depths of the 2021 bull run, STDCO emerged from the urgent need to address the growing epidemic of Solana Transmitted Diseases affecting millions of traders worldwide.

Our Origin Story

Starting with Dr. Satoshi Nakamoto discovering the first case of Pump Fatigue in 2009, our people have always been innovators and trailblazers, committed to finding the next cure. When the great Solana outbreak of 2021 hit, affecting over 69 million traders globally, our founder Dr. Chad Pumpalot knew something had to be done.

After witnessing his own portfolio suffer from severe Limp Pump Syndrome during the infamous "May 2021 Crash," Dr. Pumpalot dedicated his life to developing revolutionary treatments for crypto-related ailments.

Our Mission & Values

To boldly go where no pharmaceutical company has gone before: treating the untreatable conditions of the digital age.

Innovation First

We pioneer breakthrough treatments for conditions that didn't exist until blockchain technology emerged. From Rug Pull PTSD to Diamond Hands Syndrome, we're always first to market.

Patient-Centric

Every trader deserves access to quality healthcare, regardless of their portfolio size or how many times they've been liquidated. We believe in equal treatment for all.

Scientific Excellence

Our research is backed by over 420 clinical trials, 69,000 lab tests, and countless hours of chart analysis. We don't just follow the science—we are the science.

Leadership Team

Meet the visionaries behind STDCO's revolutionary approach to crypto-medical care.

Dr. Chad Pumpalot

CEO & Chief Medical Officer

Pioneer in Solana Transmitted Disease research. Former hedge fund manager turned medical revolutionary after experiencing severe LPS during the 2021 crash.